BioCentury
ARTICLE | Finance

Post-launch report

January 12, 2009 8:00 AM UTC

Sales through 3Q08 of selected drugs approved in 2007 and for which the company discloses sales. Product sales figures as booked by listed companies below. $M; (A) Launch of Mircera delayed in the U.S...